Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Predictive Medicine Appointments

Premium

CAMBRIDGE, Mass.--John Unger was appointed chief scientific officer and Robert Schlegel director of genomics at Millennium Predic tive Medicine (MPM). Unger joins the company--a wholly owned subsidiary of Millennium Pharmaceu ticals--with over 20 years of experience in medical diagnostics. He will lead MPM's effort to build a diagnostics and pharmacogenomics research organization. Previously, he was executive director, new technology research, at Chiron Diagnostics in Medfield, Mass. Schlegel will lead the company's genomics effort in the areas of oncology and chemoprediction. He also came to Millenni um from Chiron, where he headed genomics research. He remains an adjunct associate professor at the Harvard School of Public Health, department of cancer cell biology where he was a full time faculty member for nine years.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.